Skip to main content
OpenTrials

Clinical trial condition

ccRCC

Explore clinical trials studying ccRCC. Study availability and eligibility vary by location and protocol.

10 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

ccRCC trial results

Recruiting

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

NCT07300241

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
Locations
  • NEO-811 Los Angeles Site Duarte, California, United States
  • NEO-811 San Diego Site San Diego, California, United States
  • NEO-811 Connecticut Site New Haven, Connecticut, United States
  • NEO-811 Chicago Site Zion, Illinois, United States
View Trial Details
Recruiting

Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC

NCT07197580

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
Locations
  • Westmead Hospital Sydney, New South Wales, Australia
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • Austin Health Heidelberg, Victoria, Australia
  • Melbourne Theranostic Innovation Centre (MTIC) Melbourne N., Victoria, Australia
View Trial Details
Active, Not Recruiting

A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)

NCT02293980

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale School of Medicine New Haven, Connecticut, United States
  • University of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 25 locations
View Trial Details

Related conditions